Please assess the completion status of the following clinical trial:

Trial Title: Reduced Exposure Study Using the CHTP 1.2 With 5 Days in a Confinement Setting Followed by 85 Days in an Ambulatory Setting.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subject is aged ≥ 28 years.~* Subject is Caucasian.~* Subject is healthy, as judged by the Investigator.~* Subject has smoked at least 10 commercially available non-menthol CCs per day (no brand restrictions) at least for the last 6 weeks prior to the screening visit and admission.~* Subject has smoked at least for the last 10 years.~* Subject does not plan to quit smoking in the next 6 months.~Exclusion Criteria:~* As per Investigator judgment, the subject cannot participate in the study for any reason (e.g., medical, psychiatric, and/or social reason).~* Subject has received medication within 14 days or within 5 half-lives of the medication (whichever is longer), which has an impact on cytochrome P450 1A2 (CYP1A2) or cytochrome P450 2A6 (CYP2A6) activity.~* Female subject is pregnant or breast feeding.~* Female subject does not agree to use an acceptable method of effective contraception.

- Gender: ALL
- Minimum Age: 28 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- CHTP 1.2 (Type: EXPERIMENTAL): Ad libitum use of the CHTP 1.2
- CC (Type: ACTIVE_COMPARATOR): Ad libitum use of subject's own preferred non-menthol brand of CC

Based on this trial design, predict the completion outcome and termination type (if applicable).